Percheron Therapeutics Financial Overview
Percheron Therapeutics's market cap is currently AU$7.61M. The company's EPS TTM is AU$-0.006; its P/E ratio is ―; Percheron Therapeutics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
